SAN DIEGO, CA, November 2, 2009 - MicroConstants, Inc., a San Diego-based Contract Research Organization (CRO), today announced the appointment of Ron Shevock as their new director of business development. Ron, a former business development manager for a pharmaceutical product development company, has extensive experience selling contract research services to pharmaceutical and biotech companies at all stages of drug development.
As the director of business development at MicroConstants, Ron will be responsible for developing new business opportunities, and implementing innovative sales and marketing strategies to help increase MicroConstants’ presence in the United States as well as in international markets.
“Ron has a reputable track record for developing successful sales strategies and establishing new territories,” says president and chief scientific officer Gilbert Lam. “We believe he will be a key asset in achieving MicroConstants’ goal of becoming the recognized leader for bioanalytical and DMPK support services.”
Ron Shevock brings to MicroConstants over 10 years of sales and marketing experience in a pharmaceutical CRO environment. He has successfully established new sales territories and helped increase revenue for various CROs. Ron has a Bachelor of Science degree in Biology from King’s College in Wilkes-Barre, Pennsylvania.
MicroConstants is a GLP-compliant Contract Research Organization (CRO) that provides bioanalytical, drug metabolism, pharmacokinetic and immunology services to pharmaceutical and biotech companies worldwide. MicroConstants specializes in HPLC/MS/MS, and provides expertise in method development, validation and routine analytical testing. MicroConstants was founded in 1998 and is headquartered in San Diego, CA with a second facility in Beijing, China. For more information about MicroConstants or the contract research services they provide, please visit http://www.microconstants.com.
For more information, contact:
+1 (866) 232-9497